China Biotech Services Holdings Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Biotech Services Holdings Ltd with three other
companies in this sector in HONG KONG :
Zai Lab Ltd
sales of 379.73 million Hong Kong Dollars [US$48.88 million]
of which 100%
was commercializing proprietary therapeutic),
Golden Throat Holdings Group Co Ltd
(728.78 million Hong Kong Dollars [US$93.81 million]
Tianda Pharmaceuticals Ltd
(491.48 million Hong Kong Dollars [US$63.26 million]
of which 90%
was Pharmaceutical and Biotechnology Busines).
Sales increased substantially in 2020:
During the year ended December of 2020, sales at
China Biotech Services Holdings Ltd were HK$655.79 million (US$84.41 million).
increase of 1,007.5%
versus 2019, when the company's sales were HK$59.21 million.
Sales of Medical and Health Related Services saw an increase
1,107.7% in 2020, from
HK$53.55 million to HK$646.75 million.
Not all segments of China Biotech Services Holdings Ltd experienced an increase in sales in 2020:
sales of Pharmaceutical Products fell 40.0% to HK$869,000.00 .
(However, this segment's sales were only a very small portion of the company's overall sales).
China Biotech Services Holdings Ltd also experienced decreases in sales in
Others (down 23.0% to HK$1.30 million)